1. Home
  2. EGRX

EGRX

Eagle Pharmaceuticals Inc.

Logo Eagle Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

Founded: 2007 Country:
United States
United States
Employees: N/A City: WOODCLIFF LAKE
Market Cap: 58.1M IPO Year: 2014
Target Price: $17.00 AVG Volume (30 days): 204.8K
Analyst Decision: Sell Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.91 EPS Growth: -48.59
52 Week Low/High: $4.10 - $30.83 Next Earning Date: 05-07-2024
Revenue: $257,551,000 Revenue Growth: -5.38%
Revenue Growth (this year): -16.77% Revenue Growth (next year): -18.13%

Share on Social Networks: